# FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study

> **NCT02218775** · PHASE1 · WITHDRAWN · sponsor: **Andrew Krystal**

## Conditions studied

- Anxiety Disorders

## Interventions

- **DRUG:** LY2456302

## Key facts

- **NCT ID:** NCT02218775
- **Lead sponsor:** Andrew Krystal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding for the study ended with one subject consented, but not randomized
- **Last updated:** 2015-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218775, "FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02218775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*